Fascioliasis is the most important parasitic disease that affects humans and animals all over the world. Triclabendazole (TCBZ) is the most common drug used for the treatment of fasciolosis. This study was conducted in Bonga Sheep Breeding and Improvement Center, Kefa Zone, Ethiopia to evaluate the efficacy of Triclabendazole against Fasciola species (Fasciola hepatica and Fasciola gigantica) in naturally infected sheep. An experimental study design and purposive sampling procedure were employed from the source of sheep population. The study included 20 Bonga sheep breed naturally infected with Fasciola species and purposively selected based on their clinical signs, symptoms and faecal egg counts. Twenty (20) sheep of 2-4 years old, irrespective of sex, infested with Fasciola species were selected for this experiment and randomly divided into two equal groups (treatment and control group, n=10) each consisted of 10 sheep. Faecal samples were collected from each sheep before and after treatment. McMaster method was used to count faecal eggs. The efficacy of Triclabendazole was determined by Faecal Egg Count Reduction Test (FECRT). Descriptive statistics (means, standard error of mean and reduction percentages) were calculated to manage data. The percentage reduction in mean faecal egg count, after 14 and 21 days of treatment for Triclabendazole were 96.51% and 97.18%, respectively. Generally, this finding indicated that Triclabendazole was found effective against Fasciola species in the study area. However, appropriate use of this anthelmintic is credible to prevent future occurrence of resistance.
Keywords:
Published on: Dec 17, 2020 Pages: 178-183
Full Text PDF
Full Text HTML
DOI: 10.17352/ijvsr.000071
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."